COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices
Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.
Moderators
- Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)
Panelists
- Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
- Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
- Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)
You May Also Like
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part II– Scarring Disorders
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part II– Scarring Disorders
Navigating Scarring Eyebrow Alopecia: Diagnostic Insights and Evolving Therapeutics Have you read this recent article from the JDD? Eyebrows are a cornerstone of facial symmetry, emotional expression, and overall aesthetic…
Body Contouring By Ultrasound-Induced Lipolysis
Body Contouring By Ultrasound-Induced Lipolysis
Nonfocused Ultrasound for Noninvasive Body Contouring: New Evidence in JDD Here is a featured article from the Journal of Drugs in Dermatology that every aesthetic practitioner should have on their…
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment
From the Vault: Expert Recommendations on Microbiome Balance, Secondary Infections, and Therapeutic Gaps Managing atopic dermatitis (AD) involves navigating a complex interplay between skin barrier dysfunction and microbial dysbiosis. As…
